Kandrozid

Candesartan Cilexetil, the active ingredient in Kandrozid, is an Angiotensin II receptor blocker (ARB) presented as an oral tablet for systemic use. It is employed to lower elevated blood pressure and to improve outcomes in patients with heart failure or diabetic kidney disease.

GNH USA supplies Kandrozid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Our network ensures timely delivery and regulatory compliance across diverse markets.

Candesartan Cilexetil is an ARB that acts on the renin‑angiotensin system to manage cardiovascular conditions.

- Hypertension: reduces systolic and diastolic blood pressure, helping to lower cardiovascular risk. - Heart failure: decreases morbidity and mortality by reducing afterload and preventing cardiac remodeling. - Diabetic nephropathy: slows progression of kidney damage by lowering intraglomerular pressure and proteinuria.

Candesartan Cilexetil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Upper respiratory tract infection - Hyperkalemia (mild) - Nausea

Serious or Rare Side Effects: - Angioedema - Severe hyperkalemia - Acute renal failure - Symptomatic hypotension - Hepatic injury - Neutropenia

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor relevant parameters.

- Monitor blood pressure: adjust dose if hypertension persists or if hypotension develops. - Assess renal function: check serum creatinine and eGFR periodically. - Check serum potassium: avoid hyperkalemia, especially with potassium‑sparing agents. - Use caution in hepatic impairment: dose may need adjustment. - Avoid in patients with known hypersensitivity to candesartan or other ARBs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Candesartan Cilexetil can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - ACE inhibitors or aliskiren: combined use increases risk of hyperkalemia and renal dysfunction. - Potassium‑sparing diuretics (e.g., spironolactone): may cause dangerous elevations in serum potassium. - Lithium: candesartan can raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect and impair renal function. - Rifampin or other CYP3A4 inducers: can lower candesartan plasma concentrations. - Other antihypertensives: additive blood‑pressure lowering effect may require dose adjustments.